IISc-incubated Mynvax
IISc-incubated Mynvax 
Dealstreet

Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

Bar & Bench

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) has raised $4.2 million (₹31 crores) in its Series A funding round led by Accel.

Argus Partners advised Mynvax and the team was led by Partner Vinod Joseph along with Associate Anurag Prasad.

IndusLaw acted for Accel and the team was led by Partner Anindya Ghosh. along with Principal Associate Ashwin Krishnan and Associate Manisha Nayak.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Firing near Salman Khan house: Mother of deceased accused moves Bombay High Court for CBI probe

A critique of the Gujarat High Court order denying MBBS admission to a pani puri vendor’s son

Sarkar family feud: NCLT Kolkata dismisses plea alleging mismanagement in ABP Group

Was too ashamed: CJI DY Chandrachud recalls facing corporal punishment in school

Delhi High Court rejects PIL to stop private school from charging fees for AC

SCROLL FOR NEXT